Literature DB >> 19129754

Steady-state migrating intestinal dendritic cells induce potent inflammatory responses in naive CD4+ T cells.

S W F Milling1, C D Jenkins, U Yrlid, V Cerovic, H Edmond, V McDonald, M Nassar, G Macpherson.   

Abstract

Steady-state dendritic cells (DCs) migrating in the lymph from the intestine induce tolerance to harmless intestinal antigens, preventing inflammatory responses. To determine if such DCs are inherently tolerogenic we collected intestinal lymph DCs (L-DCs) by cannulation of the thoracic duct of rats after mesenteric lymphadenectomy, and examined their capacity to activate naive CD4+ lymphocytes in an allogeneic mixed leucocyte reaction. L-DCs stimulated strong proliferative responses, induced secretion of inflammatory cytokines including interferon-gamma, and induced FoxP3-positive lymphocytes to divide. To determine if the activated CD4+ T cells had been tolerized, they were rested and restimulated with irradiated splenocytes. The restimulated CD4+ T cells again proliferated and secreted inflammatory cytokines. These data demonstrate that the DCs, which migrate from the intestine in the steady state, are paradoxically able to induce strong inflammatory responses from naive T cells, despite their role in the maintenance of oral tolerance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19129754     DOI: 10.1038/mi.2008.71

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  9 in total

Review 1.  Dendritic cells in intestinal homeostasis and disease.

Authors:  Maria Rescigno; Antonio Di Sabatino
Journal:  J Clin Invest       Date:  2009-09-01       Impact factor: 14.808

Review 2.  Lymph node dissection--understanding the immunological function of lymph nodes.

Authors:  M Buettner; U Bode
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

3.  Transcriptomic Analysis and High-dimensional Phenotypic Mapping of Mononuclear Phagocytes in Mesenteric Lymph Nodes Reveal Differences Between Ulcerative Colitis and Crohn's Disease.

Authors:  Laurence Chapuy; Marwa Bsat; Manuel Rubio; François Harvey; Vinicius Motta; Frank Schwenter; Ramses Wassef; Carole Richard; Colette Deslandres; Bich N Nguyen; Geneviève Soucy; Nir Hacohen; Jorge Fritz; Alexandra-Chloé Villani; Heena Mehta; Marika Sarfati
Journal:  J Crohns Colitis       Date:  2020-03-13       Impact factor: 9.071

4.  Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis.

Authors:  Lotta Utriainen; Dawn Firmin; Pamela Wright; Vuk Cerovic; Maxime Breban; Iain McInnes; Simon Milling
Journal:  Arthritis Rheum       Date:  2012-10

5.  Signal regulatory protein alpha (SIRPα) regulates the homeostasis of CD103(+) CD11b(+) DCs in the intestinal lamina propria.

Authors:  Charlotte L Scott; Zangerle Murray Tfp; Katherine S H Beckham; Gillian Douce; Allan McI Mowat
Journal:  Eur J Immunol       Date:  2014-10-27       Impact factor: 5.532

6.  TLR5 mediates CD172α(+) intestinal lamina propria dendritic cell induction of Th17 cells.

Authors:  Han Liu; Feidi Chen; Wei Wu; Anthony T Cao; Xiaochang Xue; Suxia Yao; Heather L Evans-Marin; Yan-Qing Li; Yingzi Cong
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

7.  Tissue-Specific Induction of CCR6 and Nrp1 During Early CD4+ T Cell Differentiation.

Authors:  Joern Pezoldt; Jochen Huehn
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-08-23

8.  Monitoring HIV DNA and cellular activation markers in HIV-infected humanized mice under cART.

Authors:  Mary-Aude Rochat; Erika Schlaepfer; Stefan P Kuster; Duo Li; Annette Audige; Sandra Ivic; Audrey Fahrny; Roberto F Speck
Journal:  Virol J       Date:  2018-12-17       Impact factor: 4.099

9.  Tolerogenic XCR1+ dendritic cell population is dysregulated in HLA-B27 transgenic rat model of spondyloarthritis.

Authors:  Kétia Ermoza; Simon Glatigny; Nadège Jah; Vânia Camilo; Hendrick Mambu Mambueni; Luiza M Araujo; Gilles Chiocchia; Maxime Breban
Journal:  Arthritis Res Ther       Date:  2019-02-04       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.